The world of celiac disease research changes and evolves each and every day. Beyond Celiac keeps the community up-to-date on research in many ways, including our Research News Feed and the Research Opt-In.
In celiac disease, changes in the gut that persist even on a gluten-free diet may lead to an immune “scar” that could be the cause of ongoing symptoms, new research funded by Beyond Celiac has found.
Even those who have high-risk conditions for celiac disease face long delays in getting diagnosed, according to a study presented at Digestive Disease Week (DDW) by Weil Cornell Medicine and Beyond Celiac.
If you have celiac disease, get ready to pucker up without fear that kissing will expose you to gluten. A new study by researchers at Columbia University found that there is little risk of getting cross-contaminated by gluten through kissing.
Results from a clinical trial for a new drug to treat celiac disease by preventing an immune reaction to gluten with the use of nanoparticles were shared for the first time Monday at Digestive Disease Week (DDW).
Neurological symptoms of celiac disease are less well known than gastrointestinal symptoms such as diarrhea and abdominal pain. Beyond Celiac conducted a study on neurological symptoms and presented it at AAN to draw neurologists’ attention to symptoms that might not be recognized as signs of celiac disease in their patients.
A potential celiac disease vaccine could one day be a reality. Whenever new information is available we update our Research News and our Celiac Disease Vaccine page.
Researchers around the world are working to develop new treatments for celiac disease. As a person affected by celiac disease, you can play an important role in advancing research by participating in clinical trials. View our Clinical Trials Infographic to learn how clinical trials tie into to drug development process.
Additionally, Beyond Celiac has been directly involved with assisting a number of clinical studies in all phases. With the largest celiac disease social community, a robust email and research database and a website that receives over 2 million visits a year, we are uniquely qualified to help your clinical trial recruit qualified candidates. Learn about our patient recruitment offerings.
Our Chief Scientific Officers lead the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease.
Our Chief Scientist and Strategy Officer develops our research and funding priorities to impact patients in areas including clinical decision-making about disease management, treatment, and eventually a cure.
Learn more about our Science Team, as well as our Medical Advisory Council and Scientific Advisory Board.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to